-+ 0.00%
-+ 0.00%
-+ 0.00%

SILEXION THERAPEUTICS CORP - PHASE 2/3 CLINICAL TRIAL IN PANCREATIC CANCER SET FOR Q2 2026

Reuters·11/25/2025 14:15:00

Please log in to view news